BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of 82 found
  Current Search:  raptiva: 82     

HTML
100%
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient
-- Genentech, Inc.

(NYSE: DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient who had...

Drugs.com:  Oct 6 2008 5:40AM
Matching: raptiva
Find similar documents
HTML
100%
Severe Adverse Event Reported in Raptiva Patient
GENEVA, Switzerland, October 2/PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that Genentech Inc.

has reported a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient...

Drugs.com:  Oct 6 2008 5:40AM
Matching: raptiva
Find similar documents
HTML
100%
PDL taps Biogen Idec exec to oversee spinoff
San Francisco Business Times - by Ron Leuty Related News The hiring of a Biogen Idec executive to head PDL BioPharma Inc.

is raising speculation that the East Coast biotech powerhouse will take control of PDL.

Faheem Hasnain was named...

East Bay Business Journal:  Oct 6 2008 5:34AM
Matching: raptiva
Find similar documents
HTML
100%
PDL taps Biogen Idec exec to oversee spinoff
San Francisco Business Times - by Ron Leuty Related News The hiring of a Biogen Idec executive to head PDL BioPharma Inc.

is raising speculation that the East Coast biotech powerhouse will take control of PDL.

Faheem Hasnain was named...

Biz Journals:  Oct 6 2008 5:03AM
Matching: raptiva
Find similar documents
HTML
100%
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient
BUSINESS WIRE)--Genentech, Inc.

(NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient...

Pharma Live:  Oct 5 2008 10:34PM
Matching: raptiva
Find similar documents
HTML
100%
Severe Adverse Event Reported in Raptiva Patient
terms of use| privacy | copyright | site map Severe Adverse Event Reported in Raptiva Patient.
Pharma Live:  Oct 5 2008 8:49PM
Matching: raptiva
Find similar documents
HTML
100%
Another Case of PML: This Time Raptiva is Implicated
(BioWorld Today Via Acquire Media NewsEdge) Genentech Inc.

has issued an alert to the health care community about a case of a rare life-threatening brain infection in an elderly patient treated with Raptiva, making it the third...

TMC Net:  Oct 4 2008 1:29AM
Matching: raptiva
Find similar documents
HTML
100%
Another Case of PML: This Time Raptiva is Implicated
Genentech Inc.

has issued an alert to the health care community about a case of a rare life-threatening brain infection in an elderly patient treated with Raptiva, making it the third therapy to be linked to the disease.

The viral...

Calibre Macro World:  Oct 3 2008 11:59PM
Matching: raptiva
Find similar documents
HTML
100%
Another Case of PML: This Time Raptiva is Implicated
Genentech Inc.

has issued an alert to the health care community about a case of a rare life-threatening brain infection in an elderly patient treated with Raptiva, making it the third therapy to be linked to the disease.

The viral...

Therapeutics Daily:  Oct 4 2008 12:03AM
Matching: raptiva
Find similar documents
HTML
100%
Genentech Warns of Nerve Disease Cases Associated With Raptiva
A 62-year-old man taking Genentechs Raptiva for psoriasis developed progressive Genentech Warns of Nerve Disease Cases Associated With Raptiva.
FDA News:  Oct 4 2008 7:59AM
Matching: raptiva
Find similar documents
HTML
100%
STOCKS NEWS EUROPE-Thin macro, corporate diaries on Monday
0830 EZ Sentix Index Sept 1400 US Employ Index Sept ---- JP BOJ meeting No major European companies due to report.

No major U.S.

companies due to report.

Reuters Messaging rm://blaise.robinson.reuters.com@reuters.net 15:36GMT 03Oct2008...

London South East:  Oct 3 2008 11:56PM
Matching: raptiva
Find similar documents
HTML
100%
STOCKS NEWS EUROPE-FTSE Small Cap index ends up 0.2 pct
Share Price Search Search for Stock Code (eg.

VOD) or Company Name: LSE.co.uk HomeShare PricesShare ChatFinance NewsStock Market NewsMacroeconomic NewsUK Money NewsPolitics NewsInternet NewsPersonal FinanceMembers Latest Share Chat 3-OCT...

London South East:  Oct 3 2008 11:55PM
Matching: raptiva
Find similar documents
HTML
100%
STOCKS NEWS EUROPE-Stocks rise 2.9 pct on bailout hopes
Share Price Search Search for Stock Code (eg.

VOD) or Company Name: LSE.co.uk HomeShare PricesShare ChatFinance NewsStock Market NewsMacroeconomic NewsUK Money NewsPolitics NewsInternet NewsPersonal FinanceMembers Latest Share Chat 3-OCT...

London South East:  Oct 3 2008 11:55PM
Matching: raptiva
Find similar documents
HTML
100%
STOCKS NEWS EUROPE-Thin macro, c
0830 EZ Sentix Index Sept 1400 US Employ Index Sept ---- JP BOJ meeting No major European companies due to report.

No major U.S.

companies due to report.

Reuters Messaging rm://blaise.robinson.reuters.com@reuters.net 15:36GMT 03Oct2008...

London South East:  Oct 3 2008 10:58PM
Matching: raptiva
Find similar documents
HTML
100%
STOCKS NEWS EUROPE-Stocks rise 2
Share Price Search Search for Stock Code (eg.

VOD) or Company Name: LSE.co.uk HomeShare PricesShare ChatFinance NewsStock Market NewsMacroeconomic NewsUK Money NewsPolitics NewsInternet NewsPersonal FinanceMembers Latest Share Chat 3-OCT...

London South East:  Oct 3 2008 10:58PM
Matching: raptiva
Find similar documents
HTML
100%
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, Inc.

(NYSE:DNA - News) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal...

Business Wire via Yahoo!:  Oct 3 2008 7:18AM
Matching: raptiva
Find similar documents
HTML
100%
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, Inc.

(NYSE:DNA - News) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal...

Yahoo!:  Oct 3 2008 12:53AM
Matching: raptiva
Find similar documents
HTML
100%
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient
Business Editors/Health/Medical Writers SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--October 2, 2008--Genentech, Inc.

(NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers...

Macro World Investor:  Oct 2 2008 11:39PM
Matching: raptiva
Find similar documents
HTML
100%
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient
-Genentech, Inc.

(NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient who had...

Calibre Macro World:  Oct 2 2008 10:58PM
Matching: raptiva
Find similar documents
HTML
100%
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient
SOUTH SAN FRANCISCO, Calif.

- (Business Wire) Genentech, Inc.

(NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal...

Earthtimes.org:  Oct 2 2008 10:37PM
Matching: raptiva
Find similar documents
HTML
100%
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient
SOUTH SAN FRANCISCO, Calif.

Genentech, Inc.

(NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal leukoencephalopathy (PML) in a 70...

Centre Daily Times:  Oct 3 2008 6:56AM
Matching: raptiva
Find similar documents
HTML
100%
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient
Genentech, Inc.

(NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient who had...

Genetic Engineering News:  Oct 3 2008 12:36AM
Matching: raptiva
Find similar documents
HTML
100%
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Genentech, Inc.

(NYSE: DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal...

Street Insider:  Oct 2 2008 10:37PM
Matching: raptiva
Find similar documents
HTML
100%
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient
- Genentech, Inc.

(NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient who had...

DiGiTAL50:  Oct 3 2008 6:45AM
Matching: raptiva
Find similar documents
HTML
100%
UPDATE 1-Genentech: Raptiva patient develops brain disorder
LOS ANGELES, Oct 2 (Reuters) - Genentech Inc on Thursday warned doctors that a patient being treated with its psoriasis drug Raptiva has developed a rare brain infection known as progressive multifocal leukoencephalopathy, or PML.
Forbes.com:  Oct 3 2008 6:27AM
Matching: raptiva
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.